Format

Send to

Choose Destination
Med Clin North Am. 2010 Jan;94(1):19-34. doi: 10.1016/j.mcna.2009.08.020.

Treatment of fistulizing inflammatory bowel disease.

Author information

1
Division of Gastroenterology, Vanderbilt University Medical Center, Suite 514, 1211 21st Avenue, Nashville, TN 37232, USA. David.a.schwartz@vanderbilt.edu

Abstract

Fistulas manifest frequently in Crohn disease and can result in significant morbidity and often lead to the need for surgical intervention. Historically, it has been more difficult to obtain complete fistula closure in patients with perianal Crohn disease. Anti-tumor necrosis factor-alpha agents and the use of more accurate imaging modalities such as magnetic resonance imaging and rectal endoscopic ultrasound have enhanced the ability to manage fistulizing Crohn disease. A combined medical and surgical approach usually presents the best option for most patients.

Republished from

PMID:
19944796
DOI:
10.1016/j.mcna.2009.08.020

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center